Louise‐Marie Oleksiuk

Adverse Events Lead to Drug Discontinuation More Commonly among Patients Who Receive Nafcillin than among Those Who Receive Oxacillin

J. Alexander Viehman, Louise‐Marie Oleksiuk, Kathleen R Sheridan et al. · Antimicrobial Agents and Chemotherapy · 2016 · 24 citations · Full text

A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections

Neil Turco, Sandra L. Kane‐Gill, Inmaculada Hernandez et al. · Expert Opinion on Pharmacotherapy · 2018 · 15 citations

Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine

Ronald Heisel, Robert R. Sutton, Gerard P. Mascara et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 14 citations

Hematological Malignancy, Oncology, Health Sciences +15

Levofloxacin‐induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review

Jeannette Bouchard, Nicolás Peña, Louise‐Marie Oleksiuk · Journal of Clinical Pharmacy and Therapeutics · 2019 · 10 citations

Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation

James M. Kidd, Colleen Sakon, Louise‐Marie Oleksiuk et al. · Antimicrobial Agents and Chemotherapy · 2019 · 10 citations · Full text